CHEMOS
C12-200

C12-200

C12-200•LNP
Structure: C12-200 structure, CAS 1220890-25-4, MW 1136.93
Product No
CH51009
CAS
1220890-25-4
MF
C70H145N5O5
MW
1136.93
Specification
Catalog No.CH51009
CAS No.1220890-25-4
Molecular FormulaC70H145N5O5
Molecular Weight1136.93

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Overview

C12-200 (CAS 1220890-25-4, MF C70H145N5O5, MW 1136.93) is an ionizable cationic lipid analog used in LNP formulation research. Common chemistry questions involve scalable preparation of the lipid backbone, analog screening, and impurity control across batches. CHEMOS process-development team and large production base can support route refinement, scale-up and custom synthesis on request.

Applications

  • C12-200 (CAS 1220890-25-4) preparation, route refinement, and analytical-control planning
  • Ionizable lipid library and head-group / tail analog screening
  • Custom analog synthesis with controlled head-group and tail variants
  • Analytical method development for ionizable lipid related substances

Need Custom Synthesis?

Our CDMO team provides end-to-end custom synthesis support from discovery through process development and scale-up.

Explore CDMO Services